Want to see TSE:VIBE full AI Analyst Report?

Vibe Bioscience Ltd (VIBE) Price & Analysis

9 Followers

VIBE Stock Chart & Stats

C$0.45

C$0.05(12.50%)

At close: Jun 26 4:00 PM EDT

C$0.45

C$0.05(12.50%)

Day’s Range― - ―

52-Week RangeC$0.30 - C$0.95

Previous CloseN/A

Volume500.00

Average Volume (3M)6.19K

Market Cap

C$485.87K

Enterprise ValueC$2.49

Total Cash (Recent Filing)C$909.58K

Total Debt (Recent Filing)C$2.38M

Price to Earnings (P/E)―

Beta2.20

Next Earnings

Aug 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.51

Shares Outstanding1,079,699

10 Day Avg. Volume10,465

30 Day Avg. Volume6,194

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)>-0.01

Price to Sales (P/S)0.00224

P/FCF Ratio2.29

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong TTM Revenue ReboundThe sharp TTM revenue rebound indicates renewed demand and improved commercial traction. If sustained, this scale expansion can support operating leverage and strengthen the company’s position in its specialty pharmaceutical market.

Improving Operating ProfitabilityPositive EBIT and EBITDA, alongside a higher gross margin, show that operations are becoming more economically viable. Maintaining these improvements could improve earnings quality and reduce dependence on external financing over time.

Return To Positive Cash FlowThe shift to positive operating and free cash flow is a meaningful improvement from negative cash generation in 2022–2023. Continued internal cash generation would help fund operations and lessen financing pressure.

Bears Say

Negative Shareholders’ EquityNegative equity materially weakens the balance sheet and limits financial flexibility. It leaves the company more exposed to operating setbacks, refinancing needs, and potential dilution if additional capital is required.

Business Remains Loss-makingThe continuing net loss shows that operational improvements have not yet translated into bottom-line profitability. Persistent losses can consume the benefits of positive cash flow and delay balance-sheet repair.

Volatile Revenue And Limited Cash CushionThe history of uneven revenue makes the recent rebound less predictable. Because operating cash flow remains modest relative to the revenue base, a downturn or working-capital swing could quickly reduce liquidity and constrain investment.

Vibe Bioscience Ltd News

Vibe Growth Director to Reduce Stake with Share Sale

Vibe Bioscience Ltd ( ($TSE:VIBE) ) has shared an update. Mark Waldron, a director at Vibe Growth Corporation,...

1y ago

Vibe Growth Plans Strategic Share Consolidation

Vibe Bioscience Ltd (TSE:VIBE) has released an update. Vibe Growth Corporation, a leading cannabis company, has announced a...

2y ago

VIBE

VIBE FAQ

What was Vibe Bioscience Ltd’s price range in the past 12 months?

Vibe Bioscience Ltd lowest stock price was C$0.30 and its highest was C$0.95 in the past 12 months.

What is Vibe Bioscience Ltd’s market cap?

Vibe Bioscience Ltd’s market cap is C$485.87K.

When is Vibe Bioscience Ltd’s upcoming earnings report date?

Vibe Bioscience Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 5 days.

How were Vibe Bioscience Ltd’s earnings last quarter?

Currently, no data Available

Is Vibe Bioscience Ltd overvalued?

According to Wall Street analysts Vibe Bioscience Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Vibe Bioscience Ltd pay dividends?

Vibe Bioscience Ltd does not currently pay dividends.

What is Vibe Bioscience Ltd’s EPS estimate?

Vibe Bioscience Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vibe Bioscience Ltd have?

Vibe Bioscience Ltd has 1,079,699 shares outstanding.

What happened to Vibe Bioscience Ltd’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Vibe Bioscience Ltd?

Currently, no hedge funds are holding shares in TSE:VIBE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Vibe Bioscience Ltd

Vibe Growth Corp. is a vertically integrated cannabis company. The firm operates retail dispensaries, cannabis greenhouse and indoor cultivation, commercial distribution and transportation, e-commerce and home delivery, and manufacturing of marijuana products. It operates through the following segments: Dispensaries, Cultivation, Real Estate, and Canada. The company was founded on January 19, 2011 and is headquartered in Vancouver, Canada.